1. Home
  2. PCRX vs PRSU Comparison

PCRX vs PRSU Comparison

Compare PCRX & PRSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.41

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Pursuit Attractions and Hospitality Inc.

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$50.61

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
PRSU
Founded
2006
1926
Country
United States
United States
Employees
N/A
2100
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
PRSU
Price
$22.41
$50.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$30.25
$31.67
AVG Volume (30 Days)
359.7K
199.1K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
107.44
N/A
EPS
0.07
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
$4.85
Revenue Next Year
$8.54
$4.94
P/E Ratio
$324.00
$3.45
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$26.99
52 Week High
$27.64
$49.95

Technical Indicators

Market Signals
Indicator
PCRX
PRSU
Relative Strength Index (RSI) 41.76 78.56
Support Level $22.04 $32.90
Resistance Level $23.97 N/A
Average True Range (ATR) 0.74 1.24
MACD -0.02 0.39
Stochastic Oscillator 21.43 82.68

Price Performance

Historical Comparison
PCRX
PRSU

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, Iceland and Costa Rica. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

Share on Social Networks: